 |
 |
PhytoPharm issued update on Cogane , "a novel small molecule, orally bioavailable neurotrophic factor inducer that readily crosses the blood brain barrier. In preclinical models, CoganeTM stimulates the release of neurotrophic factors and increases neurite outgrowth. Importantly, CoganeTM also reverses the decrease of neurotrophic factors and reverses dopaminergic neurnal degeneration observed in vitro. see: http://www.phytopharm.com/parkinson-s-disease/ Also in their interrim report they announced they are planning for a multi-mational phase II trial to begin later this year. see http://www.phytopharm.com/assets/News-releases/Interims-HY-2010.pdf The Parkinson PipelineProject has been following the progress of this treatment for a number of years and it seems very promising. -- similar to GDNF in a pill! Linda www.pdpipeline.org __._,_.___ Your email settings: Individual Email|Traditional Change settings via the Web (Yahoo! ID required) Change settings via email: Switch delivery to Daily Digest | Switch to Fully Featured Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe __,_._,___ ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn